Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

QNTM

Quantum BioPharma Ltd

Dec 16 • 09:51AM ET

8.20

+0.45 5.76 %

Healthcare • Biotechnology • Canada • NASD

Peers: JNJ PFE MRK BMY LLY GILD REGN AMGN BIIB VRTX

| Held by: PSIL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-10.26	Insider Own	28.11%	Shs Outstand	3.82M	Perf Week	-22.90%
Market Cap	31.31M	Forward P/E	-	EPS next Y	-3.68	Insider Trans	0.00%	Shs Float	2.75M	Perf Month	11.36%
Enterprise Value	26.43M	PEG	-	EPS next Q	-1.00	Inst Own	1.78%	Short Float	4.44%	Perf Quarter	-53.88%
Income	-28.51M	P/S	-	EPS this Y	38.19%	Inst Trans	5.36%	Short Ratio	1.06	Perf Half Y	-68.15%
Sales	0.00M	P/B	3.62	EPS next Y	54.62%	ROA	-171.84%	Short Interest	0.12M	Perf YTD	122.72%
Book/sh	2.27	P/C	4.98	EPS next 5Y	-	ROE	-228.60%	52W High	38.25 -78.57%	Perf Year	94.68%
Cash/sh	1.65	P/FCF	-	EPS past 3/5Y	-131.29% -17.64%	ROIC	-329.51%	52W Low	2.70 203.56%	Perf 3Y	-84.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	13.18% 16.05%	Perf 5Y	-92.63%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-6633.39%	Oper. Margin	-	ATR (14)	1.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.39	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.32	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.41	EPS Q/Q	66.44%	SMA20	-6.46%	Beta	0.24	Target Price	45.00
Payout	-	Debt/Eq	0.30	Sales Q/Q	-	SMA50	-24.25%	Rel Volume	0.48	Prev Close	7.75
Employees	7	LT Debt/Eq	0.00	Earnings	Nov 07 BMO	SMA200	-40.54%	Avg Volume	115.16K	Price	8.20
IPO	Jun 08, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	53.53% -100.00%	Trades		Volume	5,618	Change	5.76%

Dec-10-25 08:00PM	Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update (Newsfile) -7.26%
Dec-01-25 07:00AM	Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC (GlobeNewswire) -11.65%
Nov-28-25 09:30AM	REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC (GlobeNewswire) -14.99%
Nov-27-25 04:00PM	Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC (GlobeNewswire)
Nov-26-25 09:30AM	Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 (GlobeNewswire) +41.92%
04:00PM	Loading…
Nov-25-25 04:00PM	Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5 (GlobeNewswire) +29.68%
Nov-07-25 07:00AM	Quantum Biopharma Reports Strong Third Quarter Results Maintaining 'No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio (GlobeNewswire)
Oct-31-25 07:51PM	Quantum BioPharma Ltd. Provides Corporate Update (GlobeNewswire) -11.72%
Oct-29-25 09:00PM	Quantum BioPharma Ltd. Announces Corporate Updates (Newsfile)
Oct-23-25 08:15AM	Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication (GlobeNewswire) +6.02%
Oct-20-25 08:30AM	Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend (GlobeNewswire)
Oct-14-25 08:15AM	Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group (GlobeNewswire) +5.27%
Oct-08-25 08:00AM	Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock (GlobeNewswire) -8.21%
Oct-07-25 11:00AM	Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View (ACCESSWIRE)
Oct-03-25 07:00AM	Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case (GlobeNewswire)
07:57AM	Loading…
Oct-02-25 07:57AM	Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial (GlobeNewswire) +9.50%
Oct-01-25 07:50AM	Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials (GlobeNewswire)
Sep-29-25 07:40AM	Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders (GlobeNewswire)
Sep-26-25 08:00PM	Quantum BioPharma Announces Corporate Updates (Newsfile)
Sep-24-25 08:30AM	Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025 (GlobeNewswire) -6.70%
Sep-18-25 08:10AM	Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance (GlobeNewswire) +12.49%
Sep-12-25 07:50AM	Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT (GlobeNewswire) +7.55%
Sep-10-25 07:00AM	Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target (GlobeNewswire) +27.42%
Aug-21-25 07:00AM	Quantum BioPharma Announces Corporate Updates (GlobeNewswire)
Aug-11-25 06:32PM	Quantum BioPharma Announces Update to Previously Announced Private Placement (Newsfile) -10.10% -7.35%
07:40AM	Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial (GlobeNewswire)
Aug-08-25 08:00AM	Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients (GlobeNewswire) +12.30%
Aug-07-25 07:00AM	Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt (GlobeNewswire)
Aug-05-25 07:34AM	Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS) (GlobeNewswire) -11.62%
Aug-04-25 07:33AM	Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing (GlobeNewswire) +17.30%
07:24AM	Loading…
Jul-31-25 07:24AM	Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO (GlobeNewswire)
Jul-22-25 07:00AM	Quantum BioPharma Makes Strategic Investment in GameStop Corp. (GlobeNewswire) -7.80%
Jul-08-25 08:00AM	Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom (GlobeNewswire) +5.13%
Jun-27-25 04:30PM	Quantum BioPharma Announces Private Placement (GlobeNewswire) -6.77%
04:30PM	Quantum BioPharma Announces Private Placement of 12 Class A Multiple Voting Shares at a Price of $50 Per Share (GlobeNewswire)
Jun-26-25 07:30AM	Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering (GlobeNewswire) -13.34%
Jun-18-25 09:19AM	Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress (Newsfile) +17.29%
Jun-17-25 08:00AM	Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital (GlobeNewswire) +19.95%
Jun-13-25 07:00AM	Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds (GlobeNewswire)
Jun-10-25 08:00AM	Quantum Biopharma Purchases More Bitcoin (BTC) Bringing the Total Investment in Digital Assets to USD $5,000,000 (GlobeNewswire)
Jun-03-25 07:50AM	Quantum BioPharma Clarifies It Has Not Changed Its Name (GlobeNewswire)
May-30-25 07:00AM	Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari (GlobeNewswire) +7.00%
May-29-25 07:30AM	Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc. (GlobeNewswire) +7.16%
May-28-25 08:00AM	Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome (GlobeNewswire)
May-21-25 08:00AM	Quantum BioPharma Partners with BitGo to Securely Store its Crypto Currency Assets (GlobeNewswire) +7.99%
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE) -7.10%
07:30AM	Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis (GlobeNewswire)
May-19-25 07:30AM	Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000 (GlobeNewswire) +19.61%
May-16-25 07:30AM	Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference (GlobeNewswire) +12.02%
May-12-25 08:00AM	Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis (GlobeNewswire)
May-05-25 07:08AM	Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (GlobeNewswire) +10.84%
Apr-24-25 07:00AM	Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time (GlobeNewswire)
Apr-22-25 07:00AM	Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor (GlobeNewswire)
Apr-18-25 04:00PM	Quantum BioPharma Corporate Update (Newsfile)
Apr-14-25 07:30AM	Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario (GlobeNewswire)
Apr-10-25 07:30AM	Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd (GlobeNewswire) -6.82%
Apr-03-25 07:00AM	Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico (GlobeNewswire)
Apr-01-25 02:00AM	Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis (GlobeNewswire)
Mar-31-25 07:00AM	Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms (GlobeNewswire) -9.93%
Mar-30-25 07:00PM	Quantum BioPharma Provides Corporate Update (Newsfile)
Mar-28-25 09:15AM	Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern (ACCESSWIRE)
Mar-27-25 07:00AM	Quantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors (GlobeNewswire) +20.58%
Mar-26-25 07:00AM	Quantum BioPharma Licensee Celly Nutrition Expands unbuzzd Alcohol Detox Product Lineup for Retail Sales (GlobeNewswire) +18.60%
Mar-20-25 08:09AM	Quantum Group purchases additional $1.5M worth of Bitcoin (SeekingAlpha)
07:30AM	Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies (GlobeNewswire)
Mar-17-25 11:33AM	Quantum BioPharma Unaware of Any Material Change (Newsfile) +46.83%
Mar-07-25 03:00PM	Quantum BioPharma Provides Corporate Update (Newsfile)
Feb-28-25 11:30AM	Psychedelic: GH Research, Compass Pathways report earnings results (TipRanks) -7.89%
Feb-26-25 07:30AM	Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302 (GlobeNewswire)
Feb-18-25 07:30AM	Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies (GlobeNewswire) -5.21%
Feb-11-25 07:30AM	Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program (GlobeNewswire)
Feb-10-25 07:30AM	Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs (GlobeNewswire) +8.22%
Feb-06-25 07:30AM	Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd Clinical Study (GlobeNewswire) +69.00%
Feb-04-25 08:00AM	Quantum to Release Fiscal Third Quarter 2025 Financial Results on Wednesday, February 12, 2025 (Business Wire) +111.01%
07:03AM	Quantum Biopharma Announces the Success of unbuzzd Clinical Trial (GlobeNewswire)
Jan-17-25 07:30AM	Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates (ACCESSWIRE)
Jan-14-25 08:30AM	Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM (ACCESSWIRE)
Jan-07-25 08:30AM	Quantum Biopharma Ltd. Approved to Dual List on Upstream (ACCESSWIRE)
Dec-20-24 07:30PM	Quantum Biopharma Announces Closing of Second Tranche (ACCESSWIRE) -13.29% +7.00%
09:15AM	Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency (ACCESSWIRE)
Dec-13-24 07:00PM	Quantum Biopharma Announces Closing of First Tranche (ACCESSWIRE)
Dec-10-24 07:30AM	Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) (ACCESSWIRE)
Dec-05-24 07:30AM	Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million (ACCESSWIRE)
Nov-25-24 07:00AM	Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation (ACCESSWIRE)
Oct-29-24 07:30AM	Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia (ACCESSWIRE)
Oct-28-24 11:10AM	Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma (PR Newswire)
Oct-23-24 09:30AM	Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma (PR Newswire) +15.45%
Oct-22-24 07:00AM	Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (ACCESSWIRE) -17.33%
Oct-21-24 11:55AM	Quantum BioPharma Ltd. Alleges Market Manipulation, Files Lawsuit, unbuzzed Continues To Gain Traction (News Direct) -9.80%
07:00AM	Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (ACCESSWIRE)
05:30AM	Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing (Newsfile)
Oct-15-24 06:00AM	Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd (News Direct)
Oct-07-24 08:40AM	Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America (Newsfile) -8.26%
Sep-27-24 08:06PM	Quantum Biopharma Provides Corporate Update (ACCESSWIRE)
Sep-25-24 09:20AM	Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US (ACCESSWIRE)
Sep-13-24 04:00PM	Quantum BioPharma Closes Private Placement Offering (Newsfile)
Sep-09-24 07:30AM	Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis (ACCESSWIRE)
Sep-06-24 07:30PM	Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements (ACCESSWIRE)
Aug-30-24 10:30AM	Quantum BioPharma Ltd. (QNTM) Announces Key Milestones; Price Target $12.80 (ACCESSWIRE) -8.30%
07:30AM	Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can 'own NOW and what's NEXT' (ACCESSWIRE)

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QNTM

Quantum BioPharma Ltd

Upgrade your FINVIZ experience